1 Medical Department A, National University Hospital, 2100 Ø Copenhagen, Denmark; and 2 Marion Bessin Liver Research Center, Albert Einstein College of Medicine, New York, New York 10461
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Lipopolysaccharide (LPS) initiates cholestasis. Whether this
process is mediated by tumor necrosis factor- (TNF-
) and whether the cholestatic response to LPS is associated with intrahepatic accumulation of possibly toxic substances are under debate. To study
these questions the hepatic uptake and biliary excretion of indocyanine
green (ICG) was examined in the isolated perfused rat liver 18 h after
intravenous treatment of rats with either saline, 1 mg/kg body wt LPS,
or LPS and intraperitoneal pentoxifylline (POF) (n = 6 in
each group). POF inhibits TNF-
release after LPS administration. LPS
induced a typical acute-phase response with increased mRNA for
acute-phase proteins, reduced albumin mRNA, and increased hepatic
uptake of alanine. Intrinsic hepatic clearance of ICG in controls
(1.01 ± 0.05 ml · min
1 · g
liver
1) was similarly decreased by LPS alone
(0.62 ± 0.04
ml · min
1 · g
1;
P = 0.002 vs. control) or combined with POF (0.66 ± 0.06
ml · min
1 · g
1).
A kinetic analysis indicated that LPS reduced both uptake and excretion
processes in a balanced manner, so that intrahepatic ICG content was
unaffected or even slightly reduced, as confirmed by measurement of ICG
contents in the perfused livers. In livers from parallel-treated
nonperfused rats, mRNA for the organic anion transporting protein-1
(Oatp1, which is likely to mediate ICG uptake) was unaffected by LPS,
whereas the concentration of Oatp1 protein was reduced. Thus LPS
induced an acute-phase response that included downregulation of ICG
uptake by reduction of Oatp1 protein concentration, possibly at a
posttranscriptional level. TNF-
appears not to be the mediator
because POF did not modify these LPS effects.
Oatp1; cytokines; acute-phase response; endotoxin; tumor necrosis
factor-; lipopolysaccharide
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
ALTHOUGH JAUNDICE IN SEPTIC PATIENTS is common and associated with a poor prognosis (7), the mechanism is still under investigation. The circulating bilirubin in septic patients is predominantly in the relatively nontoxic conjugated forms (29). This suggests that hyperbilirubinemia in sepsis results from altered transport of conjugated bilirubin. Hepatic transport of conjugated bilirubin includes uptake, transcellular transport, and biliary excretion. Roelofsen et al. (35) observed that both hepatic uptake and biliary excretion of conjugated bilirubin were reduced in rats 18 h after 1 mg/kg body wt iv of lipopolysaccharide (LPS) (35). Similarly, Bolder and co-workers (2) found reduced transport of sulfobromophthalein (BSP) in both basolateral and canalicular membrane vesicles from rat livers 12 h after intraperitoneal injection of LPS at 3 mg/kg body wt. They speculated that primary reduction of canalicular transport leads to accumulation of toxic compounds in the liver and that downregulation of sinusoidal uptake may be a secondary event (2) protecting against liver damage during sepsis. This clinically important hypothesis requires further investigation.
In the present study we examined the effects of LPS administration to rats on hepatic transport of indocyanine green (ICG). ICG is removed exclusively by the liver and shares transport pathways with both unconjugated (9, 38) and conjugated bilirubin (30, 43). Because ICG is excreted into the bile in unmetabolized form, it is ideal for the study of hepatic transport phenomena. A kinetic model was used to quantify the effects of LPS on uptake, excretion, and accumulation of ICG by the perfused rat liver. The organic anion transporting protein 1 (Oatp1) is a probable mediator of ICG uptake (16). Downregulation of Oatp1 has been demonstrated after bile duct ligation (6) and after 5 days of ethinyl estradiol treatment (40). To further examine the role of Oatp1 in LPS-mediated regulation of ICG transport, we also measured the expression of Oatp1 mRNA and protein. In addition, because the changes in transport after LPS injection may be a part of the hepatic acute-phase response (20), hepatic uptake of alanine and expression of mRNA for specific acute-phase proteins were assessed.
The cholestatic responses to LPS are likely to be mediated by
cytokines. Concentrations of interleukin (IL)-1, IL-6, and tumor
necrosis factor-
(TNF-
) in blood are temporarily increased (3)
after LPS administration, and these cytokines have all been related to
the hepatic acute-phase response (20). TNF-
has been advocated as a
major mediator of septic cholestasis (56), and injection of a large
dose of TNF-
was followed by an altered plasma disappearance curve
of ICG after bolus injection (51). For these reasons we hypothesized
that TNF-
mediates the LPS-induced downregulation of organic anion
transport. This hypothesis was examined in the present study by use of
pentoxifylline (POF), a methylxanthine that inhibits the increase in
plasma TNF-
concentrations after LPS without affecting the levels of
IL-6 (3).
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Materials
Female Wistar rats (Moellegaard Breeding Centre, L1. Skensved, Denmark; 65-70 days old; 180-220 g) were fed ad libitum and had free access to water. ICG was from Paesel and Lorei (Frankfurt am Main, Germany). LPS from Escherichia coli (0111:B4) (catalogue no. L4130) and taurocholate (no. T0750) were obtained from Sigma (St. Louis, MO). POF was kindly provided by Hoechst (Rodovre, Denmark). Pentobarbital sodium (thiomebumal sodium), heparin, and glucose were from Sygehusapotekerne. Human albumin was from Statens Seruminstitut (Copenhagen, Denmark). Outdated human erythrocytes were from the local blood bank. Buffer salts were from Bie and Berntsen (Roedovre, Denmark). Haemaccel was from Behringwerke (Marburg, Germany). Hypnorm [fentanyl citrate (0.315 mg/ml) and fluanisone (10 mg/ml)] was from JanssenPharma (Birkerod, Denmark). Midazolam was from Roche (Basel, Switzerland). Alanine (L-alanine no. 1007) was from Merck (Darmstadt, Germany).Study Design
Perfused livers. Rats were pretreated 18 h before examination of ICG transport and alanine uptake during once-through liver perfusion. There were three pretreatment groups: control, LPS alone, and LPS with POF (LPS + POF) (Table 1). After the perfusions, livers were frozen for later analysis of ICG content, mRNA for specific proteins, and concentration of Oatp1 protein.
Nonperfused livers. Rats were treated according to the same protocols as above. Eighteen hours later they were killed, and the livers were removed and frozen for later measurement of specific mRNAs and Oatp1 protein concentration.
Pretreatment
The pretreatment schedules are outlined in Table 1. The dose of LPS corresponds to 1 mg/kg body wt, which was enough to produce maximum TNF-
|
Series of Perfused Livers
Perfusates. Outdated packed human erythrocytes of the same blood type were obtained from the local blood bank. To avoid hemolysis, they were rejuvenated by the following procedure. The erythrocytes were transferred into sterile plastic bags containing citrate, phosphate, dextrose, and adenine (CPD-adenine, F-78310, Baxter) and kept in a 37°C water bath for 1 h. Following centrifugation, the buffy coat was removed and the erythrocytes were washed two to three times in Ringer lactate buffer containing 20,000 IU heparin/l and 5 g mannitol/l. The washed erythrocytes were stored at 4°C overnight in Ringer lactate. On the day of the perfusion the suspension was centrifuged, passed through a leukocyte filter (RC-50, Pall Biomedical), and used in the preparation of the perfusates. Perfusate 0 was prepared by gently mixing 1,099 ml of packed rejuvenated human erythrocytes (hematocrit ~0.70) with 2,400 ml Krebs-Henseleit buffer containing 102 g bovine albumin, 12 ml 50% glucose, and 164 mg taurocholate. The final concentrations of albumin (560 µmol/l), glucose (12 µmol/l), and taurocholate (112 µmol/l) are close to physiological values in the rat (8). Perfusate 1 consisted of perfusate 0 to which 0.5 µmol/l ICG and 1 µmol/l alanine were added. The perfusate hemoglobin concentrations (mean ± SD, 5.20 ± 0.14 mmol/l) and hematocrits [0.22 ± 0.01 (vol/vol)] were not statistically significantly different among treatment groups (ANOVA).
Rat liver perfusion.
On the day of the perfusion, the rats were anesthetized with 22.5 mg
pentobarbital sodium intraperitoneally, and the livers were prepared
for perfusion as previously described in detail (26). Livers were
perfused single pass at a fixed perfusion rate, aiming at 2 ml · g
liver1 · min
1. Initially, the
livers were perfused with perfusate 0 without ICG or alanine
for 35 min. After this equilibration period, perfusate 1 with
0.5 µmol/l ICG and 1 mmol/l alanine was used for 36 min. Perfusion
rate, liver temperature (aim: 37°C), and perfusate pH (7.40) were
kept stable during the experiment, and perfusion pressure was
constantly monitored. Experiments were only accepted if the bile flow
was >1
µl · g
1 · min
1,
oxygen consumption was >2
nmol · min
1 · g
1
in the experimental period, and perfusion pressure was <12 mmHg. To
avoid influence from sex differences (42), only female rats were used.
Series of Nonperfused Livers
Thirty-six female Wistar rats were divided into three groups and treated as described above (Table 1). Four animals in the LPS + POF group died after the second POF injection. The following day the remaining rats (12 controls, 12 LPS, and 8 LPS + POF) appeared healthy. They were killed by cervical dislocation. The livers were quickly removed, frozen in liquid nitrogen, and stored atAnalyses
ICG concentrations in the perfusate, liver tissue, and bile were measured by high-performance liquid chromatography as previously described (24). Alanine concentrations in the perfusate were measured enzymatically (11). Dry weight (g/g liver) was determined as weight after freeze-drying divided by weight before freeze-drying of a 1- to 2-g sample.mRNAs for specific proteins were measured in 200 mg of frozen liver
tissue after RNA extraction using Promega kit Z5110, based on the
thiocyanate method, modified by ethanol extraction as previously described (47). Northern blots were prepared using the wick method (4).
Slot blots were prepared by adding 50 µl of 10× standard saline
citrate (SSC) in each slot in a Schleicher & Schuell Minifold followed
by a 5-µg RNA sample. The following cDNA probes were used: Oatp1
(12), 1-acid glycoprotein (32),
-fibrinogen (5),
albumin (36), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(46). The probes were labeled using Amersham multiprime kit RPN 1601 Z
and isolated by a QIAquick nucleotide removal kit (Qiagen). Nothern and
slot blots were performed as previously described (47). Autoradiography
was performed on an imaging plate BASIII under lead shield, and the
signal was analyzed in a FUJIX bioimaging analyzer system BAS 2000 (Fuji Photo Film). Filters were washed and rehybridized with rat 18S
rRNA, and readings for specific mRNAs were adjusted according to the
18S reading. Because the amount of 18S rRNA is constant, we find this
way of standardization most reliable under conditions in which the
pattern of mRNA changes dramatically. However, one of the housekeeping enzymes (GAPDH) was measured for comparison.
Oatp1 protein was measured at the Albert Einstein College of Medicine
by the following method. Liver tissue was extracted with 0.1 M
Na2CO3 as previously described (1). In brief,
~0.3 g of frozen tissue was weighed, crushed, and homogenized by 25 loose Dounce strokes in 10 ml/g of 1 mM NaHCO3
containing the following protease inhibitors (Sigma):
N--benzoyl-L-arginine methyl ester (10 mg/ml), TAME (10 mg/ml), soybean trypsin inhibitor (STI) (10 mg/ml),
leupeptin (1 mg/ml), phenylmethylsulfonyl fluoride (0.2 M), EDTA (100 mM), and aprotinin (2 mg/ml). The homogenate was filtered through one
layer of cheesecloth, and the volume was brought to 35 ml by addition
of 0.1 M Na2CO3 containing protease inhibitors.
The solution was rotated at 4°C for 30 min and was then centrifuged
at 100,000 g for 1 h at 4°C. The supernatant was removed, and
the pellet was washed twice with ice-cold PBS. The resulting pellet was
resuspended in 600 µl of ice-cold PBS, divided into appropriate
aliquots, and frozen at
70°C until used. Protein concentration was
determined by the method of Lowry (18) using bovine albumin as
standard. Following 10% SDS-PAGE of 20 µg of protein, immunoblot
analysis by chemiluminescence (Renaissance kit, DuPont) was performed
in duplicate using a rabbit antibody that was prepared against a
13-amino acid peptide corresponding to the derived Oatp1 sequence near
its COOH terminus (1). A standard rat liver extract was included in
duplicate on each immunoblot and was used as an internal standard.
Intensity of immunoreactive Oatp1 was quantified after laser scanning
densitometry on a Pharmacia UltroScan XL densitometer.
Calculations
The oxygen consumption (µmol · g liverFitting Procedures
A kinetic model was fit to the data to elucidate which transport step was primarily affected by LPS. This procedure is described in APPENDIX.Statistical Evaluation
Results are reported as means ± SE or as stated. One-way ANOVA was used for statistical evaluation. Whenever this test was significant (P < 0.05), group differences were looked for with Tukey's method. A computer program (Statgraphics 6.1, Manugistics) was used for these procedures. ![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Perfused Livers
All rats survived the pretreatment in this series (n = 6 control, 6 LPS, and 6 LPS + POF livers). For the first hours after injection of LPS or LPS + POF, rats appeared lethargic and showed piloerection. On the day of perfusion they appeared normal. The body weights were not statistically different in the three groups (control: 206 ± 5 g, LPS: 201 ± 7 g, and LPS + POF: 202 ± 5 g). Details of the physiological parameters in these groups are shown in Table 2. Compared with controls, the treatment groups had slightly higher perfusion pressures and slightly lower perfusion flow rates per gram liver (Table 2). Because postperfusion liver weights were slightly higher in the LPS-treated groups (Table 2), the total perfusion rates were similar in the three groups (data not shown). Bile flow rates and oxygen consumption did not differ (Table 2). The major observations regarding ICG transport and alanine uptake are given in Table 3.
|
|
ICG uptake and excretion.
The extraction fraction of ICG was equally reduced in LPS and LPS + POF
groups compared with the control group (Fig.
1A). The mean intrinsic clearance
of ICG was clearly reduced by LPS with or without POF (Table 3). The
biliary excretion rate of ICG was always larger in the control group
than in the LPS group and the LPS + POF group (Fig.
1B). The cumulative biliary excretion of ICG was more than
twice as high in the control group than it was in LPS or LPS + POF
groups (Table 3, P = 0.001). The liver content of ICG after
36 min of perfusion was slightly lower in the LPS group, but this
difference was not statistically significant (Table 3).
|
Analysis according to the kinetic model. In both treatment groups the rate constants for influx from the sinusoidal lumen into the hepatocyte (i.e., from perfusate to liver) (kpl) and for excretion of ICG from hepatocyte to bile (kb) were lower than in the controls (Table 3). As a test of the kinetic model, the measured liver contents of ICG at the end of the experiments were compared with those predicted from the model and the fitted parameters. Reasonable agreements were observed in all groups (Table 3).
Alanine uptake.
The hepatic extraction fraction of alanine decreased more dramatically
with time than that of ICG (compare Fig. 1, A and C), so intrinsic clearance was highly time dependent. Instead, we report in
Table 3 the average hepatic extraction fraction, which is proportional
to the area under the curves in Fig. 1C. The average hepatic
extraction fraction of alanine was statistically significantly larger
in the LPS group than in the control group. In contrast to ICG
observations, the alanine uptake in the LPS + POF group showed only
intermediate LPS effect (Fig. 1C; Table 3). This suggests that
TNF- was at least partly responsible for the upregulation of alanine
uptake after LPS.
Oatp1 mRNA and protein.
With values from control rats normalized to 100 ± 13.7, Oatp1 mRNA in
the perfused livers (slot blot) was 83.5 ± 12.8 in LPS and 60.6 ± 4.1 in the LPS + POF group (Fig. 2,
P = 0.045 by ANOVA). Further evaluation with Tukey's test
pointed out only the LPS + POF group as significantly different from
the control group (Fig. 2). Oatp1 protein was reduced in the treatment
groups in parallel with the intrinsic clearance of ICG (Fig. 2). This
was not significant in the perfused livers, but because of the large variation there is a risk of a type-2 error. In the nonperfused livers
the same differences were found, and they were statistically significant (see Nonperfused Livers).
|
mRNA for other proteins.
As described in detail in MATERIALS AND METHODS, mRNA was
normalized to 18S rRNA. mRNA for acute-phase proteins such as
acid--glucoprotein [a type I acute-phase protein (20)] and
-fibrinogen (type II) were upregulated whereas mRNA for albumin [a
"negative acute-phase protein" (20)] was downregulated. In
contrast, mRNA for the housekeeping enzyme GAPDH was unaffected (Fig.
2).
Nonperfused Livers
Hepatic Oatp1 mRNA and protein are shown in Fig. 2 (n = 12 control, 12 LPS, and 8 LPS + POF livers). Changes in Oatp1 mRNA (slot blot) were of marginal significance only in the LPS + POF group. In contrast, a statistically significant reduction of Oatp1 protein was found in both LPS and LPS + POF groups compared with controls. Results for the other proteins studied were similar to results in the perfused livers (Fig. 2). Hepatic content of mRNA for Oatp1 as presented in Fig. 2 was quantified by slot blot as described in MATERIALS AND METHODS. Validity of slot blot quantification was confirmed by comparison with Northern blot in a subgroup of the nonperfused livers (n = 6 in each group). Under high-stringency conditions, two major bands of 3.3 and 4.3 kb were found (Fig. 3) as reported previously (6, 12). Because the concentration of the two bands varied linearly ( P < 0.0001, r2 = 0.91) with each other, the relative changes observed by slot blot should correctly reflect the changes of these bands. In accordance with these results, the results of the Northern blots (the 3.3-kb band) were in good agreement with results of the slot blots from the same animals (Fig. 4). The same was true with the 4.3-kb band (not shown).
|
|
Light microscopy showed only minor changes in LPS livers with a light edema of the portal area and central venous endothelium with few adjacent lymphocytes. LPS + POF and control livers were histologically normal.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the present study LPS pretreatment decreased hepatic transport of
ICG in the perfused rat liver. A kinetic analysis suggested that both
the hepatic uptake and biliary excretion of ICG were reduced. LPS
pretreatment reduced the concentration of Oatp1 protein but not Oatp1
mRNA. In contrast to ICG, hepatic alanine uptake was enhanced by LPS,
indicating an acute-phase catabolic response, and expression of
acute-phase proteins was upregulated. Addition of POF, an inhibitor of
TNF- release that is normally seen 1-3 h after LPS treatment,
did not modify the LPS effects on ICG transport.
Effects of LPS
Nonspecific or specific functional changes. LPS may produce important nonspecific effects. Thus LPS reportedly induces a 5-10% loss of body weight (45) and a small increase of liver weight (31) as in the present study (Table 2). Perfusion pressures were slightly higher in LPS livers (Table 2), as also observed by others (45). These observations could support the view that nonspecific changes induced by LPS, as, for example, disturbed microcirculation (21), lead to deterioration of liver function. However, the almost normal light microscopic appearances, the similar bile flow rates and oxygen consumptions, and the increased alanine uptake after LPS render this possibility unlikely. The latter observations strongly suggest that inhibition of hepatic ICG transport by LPS was a result of a specific downregulation of this particular liver function.
Bile flow rates. Bile flow rates were unaffected by LPS treatment (Table 2) in the presence of 112 µmol/l taurocholate in the perfusate. This is in accordance with the general observation (2, 33-35) that bile acid-dependent bile flow is unaffected whereas bile acid-independent bile flow is reduced 12-24 h after LPS. The similar bile flow rates in the groups made interpretation of the data easier because the bile flow rate did not have to be included in the kinetic model.
Indications of a hepatic acute-phase response.
LPS administration with or without POF resulted in increased expression
of mRNA for a type I acute-phase protein (1-acid glycoprotein) and a type II (
-fibrinogen) and reduced expression of
a negative acute-phase protein (albumin). Alanine uptake increased as
was also observed in septic catabolic patients (57). All together,
these findings confirm that an acute-phase response was induced by LPS
and further support the view that the livers were not structurally
damaged by endotoxemia.
Kinetic observations.
Both the uptake rate constant, kpl, and the rate
constant for excretion, kb, were reduced in the LPS
and LPS + POF groups, whereas the backflux rate constant (i.e., flux
from liver to perfusate), klp, did not
change significantly (Table 3). The backflux rate constant was included
in the compartmental model (Fig. 5) because it was the simplest way to account for the slight decline of hepatic extraction fraction of ICG with time (Fig. 1A). This
particular assumption may not be uncontroversial because such backflux
could not be demonstrated in intact pigs (23, 25). Thus backflux of ICG
may be species dependent, or the slight decline of the hepatic
extraction of ICG with time in the present study may have other causes.
In one report (35) LPS pretreatment increased the permeability of the
paracellular pathway, which could lead to increased backflux after LPS,
but such an effect was not detectable in the present study. In summary,
the LPS effect was primarily due to reduced sinusoidal uptake and
biliary excretion.
|
Postperfusion hepatic contents of ICG. Postperfusion hepatic contents of ICG were not significantly different among the groups (Table 3), in agreement with the predictions based on the kinetic model (Table 3). In one study (2), transport of cholyltaurine, chenodeoxycholyltaurin, sulfolithocholyltaurine, and BSP was reduced 12 h after LPS in vesicles of both basolateral and apical hepatocyte membranes. It was speculated that because of the large sinusoidal surface some accumulation of toxic compounds could result after LPS pretreatment (2). This would also be expected from the usual assumption that the ATP-dependent canalicular transport step is rate limiting (13). In this case, downregulation of sinusoidal transporters could be a secondary phenomenon. Rather, our data indicate a balanced reduction of transport activities with no increase of intracellular ICG after LPS. A similar finding was reported in another study (35) in which LPS pretreatment reduced the liver content of unconjugated bilirubin, whereas the contents of conjugated species were unchanged during steady-state uptake of unconjugated bilirubin in the perfused rat liver. Thus we suggest that LPS induces balanced changes of transport steps that reduce transport without significant accumulation of hepatotoxic substances. This hypothesis is in accordance with the clinical observation that transaminases are generally only moderately elevated in patients with septic cholestasis.
Oatp1 mRNA and protein concentration.
Sinusoidal uptake of ICG was assumed to be mediated by Oatp1, because
ICG reduced BSP uptake by Oatp1-transfected oocytes to 10% of the
control value (16). However, as with BSP (16, 58), the sinusoidal
membrane may have more than one ICG transporter. Although Oatp1 mRNA
was unchanged by LPS, the concentration of Oatp1 protein was almost
halved (Fig. 2). This picture was similar in the two series (Fig. 2),
although the result of the statistical evaluation was slightly
different because of higher variability in the perfused series. This
variability could be expected because of the smaller sample size and
less-optimal storage conditions in the series of perfused livers
(18°C vs.
80°C for the nonperfused livers). Our findings
should be compared with previous studies of other models of cholestasis
(6, 40). After bile duct ligation Oatp1 mRNA was dramatically reduced
(to 20% of control on day 1 and 51% at day 3),
whereas the reduction of Oatp1 protein was slower (to 90% day
1, 43% day 2) (6). These observations (6) suggest that the
half-life of Oatp1 protein is ~2 days. During daily administration of
ethynylestradiol, mRNA for Oatp1 was reduced to 28% of control after
12 h and then further decreased to 10% at day 5. Also in this
study, Oatp1 protein concentration decreased more slowly than mRNA, to
54% of control at day 1 and further to 38% at day 5. The reduction to 54% at day 1 was faster than could be
predicted from the bile duct ligation studies, suggesting enhanced
degradation of Oatp1 protein during ethynylestradiol administration. In
our study Oatp1 protein was reduced to 50% after 18 h even though mRNA
for Oatp1 was unchanged (Fig. 3). Our study cannot exclude that mRNA
for Oatp1 was reduced at some time between the pretreatment and the
measurement, but even then the observed downregulation of Oatp1 protein
is difficult to explain without assuming that the degradation of Oatp1
protein increased after LPS. A similar mechanism has been proposed for
downregulation of Ntcp protein after a larger dose (15 mg/kg) of LPS
(19), but in this case downregulation of mRNA was also observed.
Effects of POF
LPS itself is rapidly cleared from the bloodstream, and 18 h after a LPS challenge the observed effects must be mediated by stimulated compounds. These mediators could be cytokines, such as TNF-TNF- concentrations were not measured in our study. That would have
required a number of blood samples over a 1- to 2-h period after the
pretreatment, and, as blood loss itself may affect ICG transport (54,
55), this could blunt the LPS effect. The dosages used did effectively
reduce TNF-
in similar studies (3, 17, 54). TNF-
is known to
upregulate hepatic uptake of alanine (19, 27, 28) and other amino acids
(27, 28). In accordance with those findings, the alanine uptake was in
fact less upregulated in the LPS + POF group than in the LPS group
(Fig. 1C). TNF-
mediates the LPS-induced increase in liver
weight (31). Again, the increase in liver weight was less pronounced in
the LPS + POF group than in the LPS group (Table 2). Thus, in the
present study, administration of POF most likely reduced TNF-
.
POF did not modify the LPS effect on ICG transport (Table 3, Fig. 1,
A and B). The expression of mRNA for Oatp1 was not
affected by LPS, whereas LPS + POF actually reduced Oatp1 mRNA in both perfused and nonperfused livers (Fig. 2), and POF seemed to enhance the
LPS-induced reduction of Oatp1 protein in the nonperfusion series (Fig.
2). As these possible effects of POF were in the opposite direction of
our prediction, the data do not support the hypothesis that TNF-
mediated the downregulation of ICG transport 18 h after LPS injection.
In apparent conflict with this conclusion, ICG transport was reported
to be reduced 1 h after intravenous injection of 3 × 106
U/kg body wt of recombinant murine TNF- (51). Important
methodological differences may account for this. First, plasma
concentrations of TNF-
may differ from our study, and a lower dose
(6 × 105 U/kg body wt) had no effect on ICG transport
(51). Second, the conclusions of Wang et al. (51) were based on the
systemic plasma concentration decay curves of ICG after bolus injection without hepatic vein concentrations, and this method cannot separate effects of flow and of hepatocellular function. According to that analysis (51) both maximal velocity (Vmax) and
the Michelis-Menten constant (Km) for ICG
transport were similarly reduced. In such cases the first-order
intrinsic clearance (equal to
Vmax/Km) is not changed, a
fact that was overlooked (51). In addition, ICG was measured
spectrophotometrically, a procedure that may bias kinetic studies
because it is not as specific as HPLC (24). Third, these short-term (1 h) observations (51) may not be directly comparable to ours (~15 h
after the TNF-
peak). As has been pointed out by others (33), the
observation time may be very important for the comparison of studies of
the effect of LPS on transport. One to four hours after LPS injection,
bile flow is reduced (both bile acid-dependent and bile
acid-independent flow) (49, 56) as is transport of BSP (48, 49),
dinitrophenylglutathione (34), taurocholate (56), and ICG
(53). In this period there is a dramatic efflux of gluthatione with a
reduction of intracellular content (34). TNF-
seems important for
this short-term response as bile flow and Na-dependent taurocholate
transport can be protected by pretreatment with anti-TNF-
antibodies
(56). Twelve to twenty- four hours later, plasma cytokines are again
normal (3), and the hepatic glutathione storage is recovered (34). Bile
acid-independent bile flow is still reduced, while bile acid-dependent
bile flow is restored (2, 34, 35). At that time there is still a reduction of Mrp2 mRNA, protein, and function (44); Ntcp mRNA, protein,
and function (2, 10, 19, 56); uptake of unconjugated bilirubin and
ditaurine-bilirubin (35); ATP-dependent bile acid excretion (2, 19);
and Oatp1 function (Ref. 2 and present study). The importance of
TNF-
for these late (18-24 h after LPS) responses has not been
extensively investigated. Inasmuch as POF did not affect ICG transport
in the present study, it may be that TNF-
only mediates the less
specific acute effects whereas other substances mediate the later
effects of LPS.
In conclusion, LPS induced a typical acute-phase change in hepatic mRNA
for certain proteins, and the enhanced alanine uptake indicated a
hepatic shift toward catabolic functions. LPS induced a significant
reduction in both ICG uptake and excretion in a balanced way so that
the hepatic ICG content was not affected. Although mRNA for the
candidate transport protein for sinusoidal ICG uptake, Oatp1, was
unchanged, the Oatp1 protein concentration was reduced, whether because
of decreased posttranscriptional processing or accelerated degradation.
The reduction of ICG biliary excretion could in part be due to reduced
Mrp2 protein expression, but this protein is not the only canalicular
transporter for ICG. While the observed LPS effect is probably mediated
by cytokines, TNF- appears not to be involved because POF did not
change the response to LPS.
![]() |
APPENDIX |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The model illustrated in Fig. 5 was used to analyze kinetic data. The
perfusate plasma flow with a rate F carries ICG into the liver with a
constant concentration, Ci. The influx
(nmol · g
liver1 · min
1) from liver
to perfusate is assumed to be proportional to Ci and equal
to
Ci · V · kpl,
where V is the sinusoidal volume. The hepatocellular content of ICG at
time t is L(t). The backflux of ICG from liver cell
to perfusate is equal to
L(t) · klp, and the rate of
irreversible excretion of ICG from liver cell to bile [b (t)]
is equal to L(t) · kb.
Thus
![]() |
![]() |
(1) |
To reach the final formulation of Eq. 1, we used
L(t = ) = Ci · V · kpl/
(klp + kb) derived by
setting dL(t =
)/dt = 0. The kinetic model and
Eq. 1 imply that
![]() |
(2) |
![]() |
(3) |
![]() |
ACKNOWLEDGEMENTS |
---|
Technicians Mie Poulsen and Nine Scherling are acknowledged for expert assistance in liver perfusions and other laboratory work. Technicians Bjørg Krogh and Kirsten Priisholm are acknowledged for analysis of mRNA. Dr. Ester Hage, Dept. of Pathology, National University Hospital of Denmark is acknowledged for evaluation of the pathology specimen.
![]() |
FOOTNOTES |
---|
This study was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK-23026 and DK-41296) and the Danish Research Council (9601875-LPA), The Danish Foundation for the Advancement of Science, and the Danish Medical Association Research Foundation.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: P. Ott, Medical Department A, 2-12-1 Hepatology, Rigshospitalet, 2100 Ø Copenhagen, Denmark (E-mail: peterott{at}post3.tele.dk).
Received 4 September 1998; accepted in final form 19 February 1999.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Bergwerk, A. J.,
X. Shi,
A. C. Ford,
N. Kanai,
E. Jacquemin,
R. D. Burk,
S. Bai,
P. M. Novikoff,
B. Stieger,
P. J. Meier,
V. L. Schuster,
and
A. W. Wolkoff.
Immunologic distribution of an organic anion transport protein in rat liver and kidney.
Am. J. Physiol.
271 (Gastrointest. Liver Physiol. 34):
G231-G238,
1996
2.
Bolder, U.,
H. Ton-Nu,
C. D. Schteingart,
E. Frick,
and
A. F. Hofmann.
Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion.
Gastroenterology
112:
214-225,
1997[Medline].
3.
Chen, Y.-L.,
V. L. Vraux,
J.-P. Giroud,
and
L. Chauvelot-Moachon.
Anti-tumor necrosis factor properties on non-peptide drugs in acute-phase responses.
Eur. J. Pharmacol.
271:
319-327,
1994[Medline].
4.
Chomczynski, P. One-hour downward alkaline capillary transfer for
blotting of DNA and RNA. Anal. Biochem. 134-139, 1992.
5.
Crabtree, G. R.,
and
J. A. Kant.
Molecular cloning of cDNA for the ,
, and
chains of rat fibrinogen. A family of coordinately regulated genes.
J. Biol. Chem.
256:
9718-9723,
1981
6.
Dumont, M.,
E. Jacquemin,
C. D'Hont,
C. Descout,
D. Cresteil,
D. Haouzi,
M. Desrochers,
B. Stieger,
M. Hadchouel,
and
S. Erlinger.
Expression of the liver Na(+)-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation.
J. Hepatol.
27:
1051-1056,
1997[Medline].
7.
Franson, T. R.,
W. J. Hierholtzer,
and
D. R. LaBrecque.
Frequency and characteristics of hyperbilirubinemia associated with bacteremia.
Rev. Infect. Dis.
7:
1-9,
1985[Medline].
8.
Gores, J. G.,
L. J. Kost,
and
N. F. LaRusso.
The isolated perfused rat liver: conceptual and practical considerations.
Hepatology
6:
511-517,
1996.
9.
Goresky, C. A.
Initial distribution and rate of uptake of sulphobromophthalein in the liver.
Am. J. Physiol.
207:
13-26,
1964.
10.
Green, R. M.,
D. Beier,
and
J. L. Gollan.
Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents.
Gastroenterology
111:
193-198,
1996[Medline].
11.
Hansen, B. A.,
and
H. Vilstrup.
Kinetics of urea synthesis and alanine uptake by perfused rat livers.
Liver
5:
1-7,
1985[Medline].
12.
Jacquemin, E.,
B. Hagenbuch,
B. Stieger,
A. W. Wolkoff,
and
P. J. Meier.
Expression cloning of a rat liver Na(+)-independent organic anion transporter.
Proc. Natl. Acad. Sci. USA
91:
133-137,
1994[Abstract].
13.
Jansen, P. L.,
G. M. Groothuis,
W. H. Peters,
and
D. F. Meijer.
Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary-conjugated hyperbilirubinemia.
Hepatology
7:
71-76,
1987[Medline].
14.
Jansen, P. L. M.,
J.-M. van Klinken,
M. V. Gelder,
R. Ottenhoff,
and
R. P. J. O. Elferink.
Preserved organic anion transport in mutant TR rats with a hepatobiliary secretion defect.
Am. J. Physiol.
265 (Gastrointest. Liver Physiol. 28):
G445-G452,
1993
15.
Keiding, S.
Dynamic aspects of hepatic removal of circulating substances.
In: Oxford Textbook of Clinical Hepatology, edited by N. Mcintyre,
J. Benhamou,
J. Bircher,
M. Rizzetto,
and J. Rodes. Oxford, UK: Oxford, 1991, p. 78-87.
16.
Kullak Ublick, G. A.,
B. Hagenbuch,
B. Stieger,
A. W. Wolkoff,
and
P. J. Meier.
Functional characterization of the basolateral rat liver organic anion transporting polypeptide.
Hepatology
20:
411-416,
1994[Medline].
17.
LeMay, L. G.,
A. J. Vander,
and
M. J. Kluger.
The effects of pentoxifylline on lipopolysaccharide (LPS) fever, plasma interleukin 6 (IL 6), and tumor necrosis factor (TNF) in the rat.
Cytokine
2:
300-306,
1990[Medline].
18.
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr,
and
R. J. Randall.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:
265-275,
1951
19.
Moseley, R. H.,
W. Wang,
H. Takeda,
K. Lown,
L. Shick,
M. Ananthanarayanan,
and
F. J. Suchy.
Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis.
Am. J. Physiol.
271 (Gastrointest. Liver Physiol. 34):
G137-G146,
1996
20.
Moshage, H.
Cytokines and the hepatic acute phase response.
J. Pathol.
181:
257-266,
1997[Medline].
21.
Nolan, J. P.
Intestinal endotoxins as mediators of hepatic injuryan idea whose time has come again.
Hepatology
10:
887-891,
1989[Medline].
22.
Ott, P.
Hepatic elimination of indocyanine green with special reference to distribution kinetics and the influence of plasma protein binding.
Pharmacol. Toxicol.
83, Suppl. 2:
1-43,
1998[Medline].
23.
Ott, P.,
L. Bass,
and
S. Keiding.
The kinetics of continuously infused indocyanine green in the pig.
J. Pharmacokinet. Biopharm.
24:
19-44,
1996[Medline].
24.
Ott, P.,
S. Keiding,
and
L. Bass.
Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
Hepatology
18:
1504-1515,
1993[Medline].
25.
Ott, P.,
S. Keiding,
A. H. Johnsen,
and
L. Bass.
Hepatic removal of two fractions of indocyanine green after bolus injection in anaesthetized pig.
Am. J. Physiol.
266 (Gastrointest. Liver Physiol. 29):
G1108-G1122,
1994
26.
Ott, P.,
and
R. A. Weisiger.
Nontraditional effects of protein and hematocrit on uptake of indocyanine green by perfused rat liver.
Am. J. Physiol.
273 (Gastrointest. Liver Physiol. 36):
G227-G238,
1997
27.
Pacitti, A. J.,
T. R. Austgen,
and
W. W. Souba.
Adaptive regulation of alanine transport in hepatic plasma membrane vesicles from the endotoxin-treated rat.
J. Surg. Res.
51:
46-53,
1991[Medline].
28.
Pacitti, A. J.,
Y. Inoue,
and
W. W. Souba.
Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver.
J. Clin. Invest.
91:
474-483,
1993[Medline].
29.
Pirovino, M.,
F. Meister,
E. Rubli,
and
G. Karlaganis.
Preserved cytosolic and synthetic liver function in jaundice of severe extrahepatic infection.
Gastroenterology
96:
1589-1595,
1989[Medline].
30.
Potter, B. J.,
B. F. Blades,
M. D. Shepard,
S. M. Thung,
and
P. D. Berk.
The kinetics of sulfobromophthalein uptake by liver sinusoidal vesicles.
Biochem. Biophys. Acta
898:
159-171,
1987[Medline].
31.
Raina, N.,
R. G. Cameron,
and
K. N. Jeejeebhoy.
Gastrointestinal, hepatic, and metabolic effects of enteral and parenteral nutrition in rats infused with tumor necrosis factor.
JPEN
21:
7-13,
1997[Abstract].
32.
Ricca, G. A., R. W. Hamilton, J. W. McLean, A. Conn, J. E. Kalinyak,
and J. M. Taylor. Rat alpha 1-acid glycoprotein mRNA. Cloning of
double stranded cDNA and kinetics of mRNA levels following acute
inflammation. J. Biol. Chem. 10362-10368, 1981.
33.
Roelofsen, H.,
M. Muller,
and
P. L. Jansen.
Regulation of organic anion transport in the liver.
Yale J. Biol. Med.
70:
435-445,
1997[Medline].
34.
Roelofsen, H.,
B. Schoemaker,
C. Bakker,
R. Ottenhoff,
P. L. Jansen,
and
R. P. Elferink.
Impaired hepatocanalicular organic anion transport in endotoxemic rats.
Am. J. Physiol.
269 (Gastrointest. Liver Physiol. 32):
G427-G434,
1995
35.
Roelofsen, H.,
C. N. Ven der Veere,
R. Ottenhoff,
B. Schoemaker,
P. L. M. Jansen,
and
R. P. J. O. Elferink.
Decreased bilirubin transport in the perfused liver of endotoxemic rats.
Gastroenterology
107:
1075-1084,
1994[Medline].
36.
Sargent, T. D.,
M. Yang,
and
J. Bonner.
Nucleotide sequence of cloned rat serum albumin messenger RNA.
Proc. Natl. Acad. Sci. USA
78:
243-246,
1981[Abstract].
37.
Sathirakul, K.,
H. Suzuki,
K. Yasuda,
M. Hanano,
O. Tagaya,
T. Horie,
and
Y. Sugiyama.
Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
J. Pharmacol. Exp. Ther.
265:
1301-1312,
1993[Abstract].
38.
Scharschmidt, B. F.,
J. G. Waggoner,
and
P. D. Berk.
Hepatic organic anion uptake in the rat.
J. Clin. Invest.
56:
1280-1292,
1975[Medline].
39.
Sherman, M. L.,
D. R. Spriggs,
K. A. Arthur,
K. Imamura,
E. Freid,
and
D. W. Kufe.
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.
J. Clin. Oncol.
6:
344-350,
1988[Abstract].
40.
Simon, F. R.,
J. Fortune,
M. Iwahashi,
C. Gartung,
A. Wolkoff,
and
E. Sutherland.
Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters.
Am. J. Physiol.
271 (Gastrointest. Liver Physiol. 34):
G1043-G1052,
1996
41.
Simpson, K. J.,
N. W. Lukacs,
L. Colletti,
R. M. Strieter,
and
S. L. Kunkel.
Cytokines and the liver.
J. Hepatol.
27:
1120-1132,
1997[Medline].
42.
Sorrentino, D.,
V. Licko,
and
R. A. Weisiger.
Sex differences in sulphobromophthalein-glutathione transport by perfused rat liver.
Biochem. Pharmacol.
37:
3119-3126,
1988[Medline].
43.
Stremmel, W.,
and
P. D. Berk.
Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein.
J. Clin. Invest.
78:
822-826,
1986[Medline].
44.
Trauner, M.,
M. Arrese,
C. J. Soroka,
M. Ananthanarayanan,
T. A. Koeppel,
S. F. Schlosser,
F. Suchy,
D. Keppler,
and
J. L. Boyer.
The rat canalicular conjugate export pump (mrp2) is downregulated in intrahepatic and obstructive cholestasis.
Gastroenterology
113:
255-264,
1997[Medline].
45.
Trauner, M.,
M. H. Nathanson,
S. A. Rydberg,
T. A. Koeppel,
C. Gartung,
W. C. Sessa,
and
J. L. Boyer.
Endotoxin impairs biliary glutathione and HCO3 excretion and blocks the choleretic effect of nitric oxide in rat liver.
Hepatology
25:
1184-1191,
1997[Medline].
46.
Tso, J. Y., X. Sun, T. Kao, K. S. Reece, and R. Wu. Isolation and
characterization of rat and human glyceraldehyde-3-phosphate
dehydrogenase cDNAs: genomic and molecular evolution of the gene.
Nucleic Acids Res. 2485-2502, 1985.
47.
Tygstrup, N.,
S. Bak,
B. Krog,
A. Pietrangelo,
and
D. A. Shafritz.
Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat.
J. Hepatol.
22:
349-355,
1995[Medline].
48.
Utili, R.,
C. O. Abernathy,
and
H. J. Zimmerman.
Cholestatic effects of Escherichia coli endotoxin on the isolated perfused rat liver.
Gastroenterology
70:
248-253,
1976[Medline].
49.
Utili, R.,
C. O. Abernathy,
and
H. J. Zimmerman.
Studies on the effects of E. coli endotoxin on canalicular bile formation in the isolated perfused rat liver.
J. Lab. Clin. Med.
89:
471-482,
1977[Medline].
50.
Waage, A.
Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone.
Clin. Immunol. Immunopathol.
45:
348-355,
1987[Medline].
51.
Wang, P.,
A. Ayala,
Z. F. Ba,
M. Zhou,
M. M. Perrin,
and
I. H. Chaudry.
Tumor necrosis factor- produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation.
Am. J. Physiol.
265 (Gastrointest. Liver Physiol. 28):
G126-G132,
1993
52.
Wang, P.,
Z. F. Ba,
J. Burkhardt,
and
I. H. Chaudry.
Measurement of hepatic blood flow after severe hemorrhage:lack of restoration despite adequate resuscitation.
Am. J. Physiol.
262 (Gastrointest. Liver Physiol. 25):
G92-G98,
1992
53.
Wang, P.,
Z. F. Ba,
and
I. H. Chaudry.
Hepatocellular dysfunction occurs earlier than the onset of hyperdynamic circulation during sepsis.
Shock
3:
21-26,
1995[Medline].
54.
Wang, P.,
Z. F. Ba,
M. H. Morrison,
A. Ayala,
and
I. H. Chaudry.
Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma hemorrhage and resuscitation.
Surgery
112:
451-457,
1992[Medline].
55.
Wang, P.,
J. G. Hauptman,
and
I. H. Chaudry.
Hepatocellular dysfunction occurs early after hemorrhage and persists despite fluid resuscitation.
J. Surg. Res.
48:
464-470,
1990[Medline].
56.
Whiting, J. F.,
R. M. Green,
A. B. Rosenbluth,
and
J. L. Gollan.
Tumor necrosis factor- decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis.
Hepatology
22:
1273-1278,
1995[Medline].
57.
Wilmore, D. W.,
C. W. Goodwin,
L. H. Aulick,
M. C. Powanda,
A. D. Mason,
and
B. A. Pruitt.
Effect of injury and infection on visceral metabolism and circulation.
Ann. Surg.
192:
491-504,
1980[Medline].
58.
Wolkoff, A. W.
Hepatocyte surface membrane organic anion binding proteins.
In: Hepatic Transport and Bile Secretion, edited by N. Tavoloni,
and P. D. Berk. New York: Raven, 1993, p. 269-280.